E Durante

595 total citations
25 papers, 437 citations indexed

About

E Durante is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, E Durante has authored 25 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Surgery. Recurrent topics in E Durante's work include Lung Cancer Treatments and Mutations (7 papers), Gastric Cancer Management and Outcomes (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). E Durante is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Gastric Cancer Management and Outcomes (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). E Durante collaborates with scholars based in Italy, Switzerland and Belarus. E Durante's co-authors include Felice Pasini, Giovanni De Manzoni, Giuseppe Pelosi, Corrado Pedrazzani, Claudio Cordiano, Alberto Terzi, Filippo Fraggetta, Giuseppe Viale, Ugo Pastorino and Angelica Sonzogni and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

E Durante

22 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Durante Italy 10 229 152 143 99 83 25 437
Mayur Parepally United States 6 88 0.4× 125 0.8× 75 0.5× 53 0.5× 52 0.6× 8 304
Hideki Ushiku Japan 15 191 0.8× 151 1.0× 159 1.1× 20 0.2× 228 2.7× 39 478
Shung‐Haur Yang Taiwan 10 81 0.4× 85 0.6× 136 1.0× 15 0.2× 54 0.7× 17 274
James P. De Andrade United States 12 100 0.4× 70 0.5× 134 0.9× 16 0.2× 195 2.3× 25 400
Manoj Shah India 11 112 0.5× 79 0.5× 163 1.1× 17 0.2× 121 1.5× 29 346
Elizabeth Smyth United Kingdom 9 95 0.4× 101 0.7× 208 1.5× 10 0.1× 144 1.7× 20 447
Anders Bjartell Sweden 5 190 0.8× 43 0.3× 44 0.3× 37 0.4× 116 1.4× 12 333
Sandra Waalkes Germany 12 217 0.9× 81 0.5× 79 0.6× 17 0.2× 234 2.8× 27 407
E Antoine France 7 160 0.7× 31 0.2× 294 2.1× 8 0.1× 112 1.3× 16 461
Michael L. Palmer United States 11 121 0.5× 123 0.8× 156 1.1× 5 0.1× 136 1.6× 17 457

Countries citing papers authored by E Durante

Since Specialization
Citations

This map shows the geographic impact of E Durante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Durante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Durante more than expected).

Fields of papers citing papers by E Durante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Durante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Durante. The network helps show where E Durante may publish in the future.

Co-authorship network of co-authors of E Durante

This figure shows the co-authorship network connecting the top 25 collaborators of E Durante. A scholar is included among the top collaborators of E Durante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Durante. E Durante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fiorica, Francesco, Matteo Bauckneht, Jacopo Giuliani, et al.. (2025). Is [177Lu]Lu-PSMA-617 Redefining Value in mCRPC Care? A Meta-Analysis of Clinical and Economic Endpoints. Cancers. 17(13). 2247–2247.
2.
3.
4.
Napoli, Giuseppe, Stefano Arcangeli, Bruno Fionda, et al.. (2022). A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). Current Oncology Reports. 24(11). 1633–1644. 9 indexed citations
5.
Piacentini, Paolo, Filippo Greco, Anna Mercanti, et al.. (2014). Platinum doublets as first-line treatment for elderly patients with advanced non-small cell lung cancer.. PubMed. 99(6). 650–5. 3 indexed citations
6.
Pasini, Felice, Anna Paola Fraccon, Carmen Barile, et al.. (2013). Targeted therapies (TT) in metastatic renal cell carcinoma (mRCC): An Italian survey of 902 pts.. Journal of Clinical Oncology. 31(15_suppl). e15514–e15514. 1 indexed citations
7.
Piacentini, Paolo, Filippo Greco, Anna Mercanti, et al.. (2013). Platinum doublets as first-line treatment for elderly patients with advanced non-small cell lung cancer. Tumori Journal. 99(6). 650–655. 3 indexed citations
8.
9.
Gridelli, Cesare, Carmine Ferrara, Ciro Guerriero, et al.. (2007). Informal Caregiving Burden in Advanced Non-small Cell Lung Cancer: The HABIT study. Journal of Thoracic Oncology. 2(6). 475–480. 21 indexed citations
10.
11.
Manzoni, Giovanni De, Corrado Pedrazzani, Felice Pasini, et al.. (2003). Pattern of recurrence after surgery in adenocarcinoma of the gastro-oesophageal junction. European Journal of Surgical Oncology. 29(6). 506–510. 48 indexed citations
12.
Pasini, Felice, Giovanna Verlato, E Durante, et al.. (2003). Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years. British Journal of Cancer. 88(11). 1666–1668. 14 indexed citations
13.
Pelosi, Giuseppe, Ugo Pastorino, Felice Pasini, et al.. (2003). Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. British Journal of Cancer. 88(4). 537–547. 160 indexed citations
14.
Pasini, Felice, et al.. (2003). High-dose chemotherapy in small-cell lung cancer.. PubMed. 22(6B). 3465–72. 15 indexed citations
15.
Pasini, Felice, Giuseppe Pelosi, F. Valduga, et al.. (2002). Late events and clinical prognostic factors in stage I non small cell lung cancer. Lung Cancer. 37(2). 171–177. 19 indexed citations
16.
Manzoni, Giovanni De, Giuseppe Pelosi, Alfredo Di Leo, et al.. (2002). The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients. British Journal of Cancer. 86(7). 1047–1051. 19 indexed citations
17.
Manzoni, Giovanni De, Corrado Pedrazzani, Felice Pasini, et al.. (2002). Results of surgical treatment of adenocarcinoma of the gastric cardia. The Annals of Thoracic Surgery. 73(4). 1035–1040. 52 indexed citations
18.
Heerden, Jaques van, et al.. (1993). Experimental vermeersiekte (Geigeria ornativa O. Hoffm. poisoning) in sheep. I: An evaluation of diagnostic aids and an assessment of the preventive effect of ethoxyquin.. PubMed. 64(2). 76–81. 5 indexed citations
19.
Marchetti, Elisabetta, Alberto Bagni, Patrizia Querzoli, et al.. (1989). Immunocytochemical detection of estrogen receptors by staining with monoclonal antibodies on cytologic specimens of human breast cancer.. PubMed. 32(6). 829–34. 12 indexed citations
20.
Durante, E, et al.. (1986). Anaplastic adenocarcinoma of the thyroid gland: a study of ten cases.. PubMed. 16(3). 205–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mayur Parepally Breakdown of academic impact, for papers by Hideki Ushiku Breakdown of academic impact, for papers by Shung‐Haur Yang Breakdown of academic impact, for papers by James P. De Andrade Breakdown of academic impact, for papers by Manoj Shah Breakdown of academic impact, for papers by Elizabeth Smyth Breakdown of academic impact, for papers by Anders Bjartell Breakdown of academic impact, for papers by Sandra Waalkes Breakdown of academic impact, for papers by E Antoine Breakdown of academic impact, for papers by Michael L. Palmer
Rankless by CCL
2026